Brookside Energy Ltd has materially increased the known oil reserves within its oil and gas assets and interests, raising its proved developed producing (PDP) net reserves by 50.1% to 2.65 million barrels of oil equivalent (BOE) and its total proved (1P) net reserved by 21.8% to 4.98 million BOE.
The new numbers were independently produced by Haas & Cobb Petroleum Consultants, demonstrating an uplift in both revenue generating assets and BRK’s long-term reserve base, according to Brookeside.
Candel Therapeutics Inc (NASDAQ:CADL) said on Wednesday that its experimental immunotherapy, CAN-2409, demonstrated prolonged median overall survival in a Phase 2a clinical trial for patients with advanced non-small cell lung cancer (NSCLC) who had not responded to immune checkpoint inhibitors (ICI).
Patients receiving CAN-2409 showed a median overall survival of 24.5 months, exceeding historical survival rates for this population, the company said.
Nano One Materials Corp (TSX:NANO, OTC:NNOMF) continues to strengthen its financial position and advance strategic initiatives, the company has emphasized while reporting its fourth quarter financial results on Wednesday.
The company said that it exited the fourth quarter, which ended on December 31, with $21.4 million in net assets and $5.5 million in working capital.
New Gold Inc. (TSX:NGD) received a double upgrade to 'Buy' from 'Underperform' and a 50% increase in its price target to C$5.45 ($3.90) from Bank of America, as the company’s operational turnaround gains momentum.
The upgrade comes as the company sees strong growth in both gold and copper production, falling unit costs, and an inflection point in free cash flow generation.
Summit Therapeutics PLC (NASDAQ:SMMT) has been upgraded to a ‘Buy’ rating by Citi analysts who are optimistic about the company’s HARMONi-2 trial of ivonescimab in non-small cell lung cancer.
Citi also boosted its price target to $35. Shares of Summit traded hands at $20 late morning on Wednesday.
GameStop Corp (NYSE:GME) posted a rare operating profit for the fourth quarter despite a sharp decline in revenue, prompting Wedbush analysts to boost their price target on the video game retailer while repeating their ‘Underperform’ rating.
“We are raising our price target from $10 to $11.50 to reflect the company’s cash balance of approximately $10.50 per share plus $1 in going concern value,” the analysts wrote.
EnWave Corp (TSX-V:ENW, OTC:NWVCF) announced that it has signed a new royalty-bearing commercial license with Hokkai Yamato Foods Japan, a Sapporo-based food manufacturer specializing in soups, furikake, ochazuke, and other processed foods.
Hokkai Yamato has purchased a 10kW Radiant Energy Vacuum (REV) machine for product development and early-stage commercial production in the Japanese market.
GameStop Corp (NYSE:GME) shares are up 13% premarket on Wednesday after the company announced plans to invest in bitcoin.
The board unanimously approved an update to its investment policy, allowing the video game retailer to hold Bitcoin as a treasury reserve asset.
Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF), the only longevity-focused biotech listed in Europe, has secured a £434,083 equity investment from a major institution to support its gene therapy research targeting age-related decline in dogs.
The investment, announced on Wednesday, will fund a new clinical trial using Genflow’s proprietary SIRT6 gene therapy in aged animals -marking a significant step in the company’s push to develop treatments aimed at slowing the ageing process.
In the wake of Livium Ltd’s binding agreement with the Australian Renewable Energy Agency (ARENA) for a grant of up to A$30 million, wholly owned subsidiary VSPC Pty Ltd has intensified its efforts to close the remaining A$30 million funding gap for its lithium ferro phosphate (LFP) Demonstration Plant, engaging with a broad range of investors.
Over recent weeks, the company has also expanded its potential customer base, including several large electric vehicle original equipment manufacturers (EV OEMs). The cumulative indicative demand from these prospective customers exceeds 300,000 tonnes per annum—more than 12 times the capacity of a 25,000 tonnes per annum LFP manufacturing facility.